COMP <GO>
DNLI vs IOVA // ENTERPRISE SCALE & MARKET CAP
Denali Therapeutics Inc. (NASDAQ) VS. Iovance Biotherapeutics Inc. (NASDAQ) • 15-METRIC TALLY: DNLI 2
— IOVA 3
▲ ENTERPRISE SCALE & MARKET CAP LEADER: IOVA
LAST: $18.86 (-0.42%) • MKT CAP: $3.01B
market-cap
$3.01B
LAST: $8.02 (-5.42%) • MKT CAP: $3.63B
market-cap
$3.63B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DNLI VS. IOVA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DNLI | IOVA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 34.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -13.67% | -7.76% | -5.91 | IOVA | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 60.60% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 10.87 | 7.08 | +3.79 | DNLI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 4/9 | -2.00 | IOVA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.0 | 31.8 | +13.20 | DNLI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.99 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 33.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $3.01B | $3.63B | -$618.1M | IOVA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DNLI REV | IOVA REV | DNLI GROSS % | IOVA GROSS % | DNLI FCF | IOVA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.55B | $263.5M | — | 34.3% | -$422.1M | -$336.2M |
| FY 2024 | $1.36B | $164.1M | — | 43.2% | -$363.6M | -$364.0M |
| FY 2023 | $330.5M | $1.2M | — | — | -$358.0M | -$361.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DNLI // BETA —
IOVA // BETA 0.99